Skip to main content

Search form

Medicines for Malaria Venture

Developing antimalarials to save lives

  • Research & Development
    • MMV-supported projects
    • R&D areas of work
      • Next-generation medicines
      • Products for key populations
    • Working with regulators
    • Information for scientists
      • Malaria online course
      • Global health compound design webinars
      • Call for proposals
      • TPPs & TCPs
      • Learning resources for scientists
    • Project of the year award
    • Computational chemistry
    • R&D challenges
  • Access
    • Products & projects
    • Product availability maps
    • Areas of work
      • Supporting introduction
      • Enhancing reach
      • Informing R&D
      • Gathering market intelligence
    • Tool Kits
      • Injectable Artesunate tool kit
      • Artesunate rectal capsules tool kit
      • Seasonal Malaria Chemoprevention tool kit
    • Access challenges
  • Partnering
    • The PDP model
    • Our partner network
    • Our donors
      • Current donors
      • Past donors
    • Donate to MMV
    • Socially responsible agreements
    • Our clinical centre partners
  • Our impact
    • Milestones
    • Real life stories
    • Better medicines for children
    • Gender equity
    • Global health security
      • Malaria and COVID-19
      • Tackling antimicrobial resistance
  • About us
    • What we do
      • An overview of our work
      • Our strategic focus
      • Our history
    • People & governance
      • Staff bios
      • Staff interviews
      • Board of Directors
      • MMV North America Board
      • Expert Scientific Advisory Committee
      • Access & Product Management Advisory Committee
      • Global Safety Board
    • Work with us
      • Jobs
      • RFPs/RFIs
    • Policies
    • Diversity at MMV
    • Funding and expenditure
    • FAQs
    • Contact us
  • Malaria & medicines
    • Definitions and symptoms
    • Five species
    • Parasite lifecycle
    • Malaria facts & figures
    • Malaria treatment
    • History of antimalarials
  • Newsroom
    • News & Press Releases
    • Audio
      • Media interviews
      • Speaking of Malaria podcast
    • Films
    • Infographics
    • Interviews
    • Image slideshows
    • Publications
    • Events
  • MMV Open
    • Malaria Libre
      • About Malaria Libre
      • Participate in Malaria Libre
      • Malaria Libre data repository
    • MMVSola
      • About MMVSola
    • Pandemic Response Box
      • About the Pandemic Response Box
      • Request the Pandemic Response Box
      • Supporting information
      • Terms & conditions
    • COVID Box
      • About the COVID Box
      • Supporting information
      • COVID Box terms and conditions
    • Archived projects
      • Pathogen Box
      • Malaria Box
    • MMV Open Team
    • Contact us
  • Home
  • Our impact
  • Milestones

Milestones

Click on each one of the boxes below to learn more about MMV's work in the area mentioned. 

SDG 1: Access to antimalarials is key to eliminating malaria, a major cause of poverty

SDG 3: MMV's work supports target 3.3, which aims to end the epidemics of AIDS, tuberculosis, malaria and NTDs

SDG 5: MMV prioritizes the needs of women and girls, a key population at risk of malaria

SDG 8: Availability of antimalarials for workers and their families decreases absenteeism in the workplace

SDG 9: MMV invests in partnerships, including those which strengthen capacity in Africa

SDG 10: MMV's vision is a world in which antimalarials cure and protect the most vulnerable

SDG 17: Partnership is at the core of MMV's business model

Almost 3 million lives estimated to have been saved by MMV-supported medicines

Graphic: MMV's key milestones in 2020

>25 drug targets validated since 1999

MMV's key achievements from 1999-2019

150 active partners in MMV's network, working to help defeat malaria

Graphic: MMVs key achievements from 1999-2014

USD 1 = USD 3.5 of investment impact thanks to direct and in-kind support from partners

  • RSS subscribe
    Printer friendly

Follow us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

Previous newsletters

Contact us

  • Tel: +41 22 555 03 00

    • Message us
    • Office directions
© MMV 2022
Website by Manta Ray Media
  • Glossary
  • Disclaimer
  • Privacy
  • Sitemap